Medication info
Il Yang Bio Losartan Potassium Tablet 50 mg

Il Yang Bio Losartan Potassium Tablet 50 mg

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Il Yang Bio Pharm Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603050 · Approved 2016.05.30

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Special patient populations No adjustment of the initial dose is necessary in elderly patients up to 75 years of age. For patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Il Yang Bio Pharm Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It also helps to prevent and treat kidney disease in patients with type 2 diabetes, particularly in those with hypertension. Therefore, it is expected to contribute to blood pressure control and protection of kidney function simultaneously. This drug plays a significant role in managing hypertension and improving diabetic kidney disease.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Special patient populations No adjustment of the initial dose is necessary in elderly patients up to 75 years of age. For patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). For patients with a history of hepatic impairment, consider administering a lower dose. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause severe harm to the fetus, especially when taken in the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Taking this medication during pregnancy may hinder the development of the fetal lungs or cause skeletal malformations; it may also pose risks to newborns, including decreased skull formation, anuria, hypotension, and renal failure. Patients with hypersensitivity to this drug, severe liver impairment, hereditary angioedema, pregnant women, or women who may become pregnant should not take it. Particular caution is required for patients with diabetes or moderate to severe renal dysfunction, as the risk may increase when combined with certain medications. Elderly patients, those with hyperkalemia, liver disorders, or cardiovascular diseases should use this medication cautiously, and regularly monitor blood pressure, renal function, and electrolyte status. While this drug is generally well-tolerated, side effects such as dizziness, myalgia, cough, and dyspepsia may occur. Angioedema or allergic reactions may rarely occur, so if unusual symptoms appear, consult a physician immediately. During treatment with this drug, avoid the use of potassium supplements or potassium-containing salt substitutes, and exercise caution when combined with other antihypertensives or non-steroidal anti-inflammatory drugs (NSAIDs). This drug may affect liver and kidney function, so dosage adjustments may be necessary for patients with liver cirrhosis or kidney disease. Be cautious while driving or operating machinery due to the potential for dizziness, and it is advisable to discontinue use at least 24 hours prior to surgery. In case of overdose, symptoms such as hypotension and bradycardia may occur, and immediate medical attention is required. This medication is not recommended for children or adolescents under 6 years of age due to established safety and efficacy.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • lumbar pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 124 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neurogenic hyperexcitability
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • throat discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • reduced vision
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythema multiforme
  • hyponatremia
  • ALT elevation
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic contraction
  • hypoglycemia
  • shock symptoms due to hypotension
  • loss of consciousness due to hypotension
  • dyspnea due to hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to prevent air or moisture from entering. It is advisable to maintain storage temperature between 1°C and 30°C to ensure the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.